Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05668988
PHASE3

A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)

Sponsor: Dizal Pharmaceuticals

View on ClinicalTrials.gov

Summary

This is a phase 3, open-label, randomized, multi-center study assessing the efficacy and safety of DZD9008 versus platinum-based doublet chemotherapy in participants with locally advanced or metastatic NSCLC with EGFR Exon20ins mutation, who are newly diagnosed or have not received prior systemic therapy in advanced stage. Primary objective of this study is to assess the efficacy of DZD9008 versus platinum-based doublet chemotherapy using by BICR-assessed PFS per RECIST 1.1 as primary endpoint. Approximately 320 participants are estimated to be randomized into the study. Participants enrolled will be randomized to DZD9008 or platinum-based doublet chemotherapy in a 1:1 manner, stratified by baseline brain metastasis (with/without).

Official title: A Phase 3, Open-Label, Randomized, Multi-Center Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertion Mutation

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

324

Start Date

2022-12-13

Completion Date

2027-10-31

Last Updated

2026-10-29

Healthy Volunteers

No

Interventions

DRUG

sunvozertinib

orally, 300 mg, once daily until a treatment discontinuation criterion is met.

DRUG

Pemetrexed+carboplatin

Participants randomized into chemotherapy arm can receive up to 6 cycles of pemetrexed + carboplatin (pemetrexed 500 mg/m2 + carboplatin area under the plasma concentration-time curve 5 mg/ml per minute (AUC5), IV infusion, every 3 weeks) as the initial treatment. Participants whose disease has not progressed after 4 cycles of first-line platinum-based doublet chemotherapy may receive pemetrexed maintenance monotherapy until a treatment discontinuation criterion is met.

Locations (154)

OPN Healthcare, Inc.

Glendale, California, United States

Kaiser Permanente Medical Center

Vallejo, California, United States

University of Colorado Hospital - Anschutz Cancer Pavilion

Aurora, Colorado, United States

D&H Cancer Research Center LLC

Margate, Florida, United States

BRCR Medical Center Inc.

Plantation, Florida, United States

NYU Langone Health

New York, New York, United States

NYU Laura & Issac Perlmutter Cancer Center at NYU Langone Health

New York, New York, United States

Columbia University Medical Center

New York, New York, United States

Gabrail Cancer Center Research

Canton, Ohio, United States

OSU Brain & Spine Hospital

Columbus, Ohio, United States

Providence Portland Institute Franz

Portland, Oregon, United States

Texas Oncology - Baylor Charles A. Sammons Cancer Center

Dallas, Texas, United States

The University of Texas MD Anderson cancer center

Houston, Texas, United States

exas Oncology--McAllen

Weslaco, Texas, United States

University of Virginia Comprehensive Cancer Center

Charlottesville, Virginia, United States

Centro Medico Austral

Buenos Aires, Argentina

Consultorios Medicos Dr. Doreski - Fundacion Respirar

Buenos Aires, Argentina

Fundacion Cenit Para El Estudio De Neurociencias

Buenos Aires, Argentina

Instituto Argentino de Diagnositco y Tratamiento S.A

Buenos Aires, Argentina

Fundación Estudios Clínicos

Rosario, Argentina

Fundación Ars Médica

San Salvador, Argentina

Concord Repatriation General Hospital

Concord, Australia

Peter MacCallum Cancer Centre

Melbourne, Australia

Sir Charles Gairdner Hospital

Nedlands, Australia

Prince of Wales Hospital

Randwick, Australia

Ordensklinikum Linz GmbH Elisabethinen

Linz, Austria

Uniklinikum Salzburg Universitatsklinik fur Innere Medizin Ⅲ

Salzburg, Austria

Universitair Ziekenhuis Antwerpen

Edegem, Antwerp, Belgium

UZ Gent

Ghent, Flanders, Belgium

Grand Hopital de Charleroi

Charleroi, Hainaut, Belgium

Fundacao PIO XII - Hospital do Cancer de Barretos

Barretos, Brazil

Hospital Evangelico de Cachoeiro de Itapemirim

Cachoeiro de Itapemirim, Brazil

Liga Norte Riograndense Contra o Câncer

Natal, Brazil

Irmandade da Santa Casa de Misericordia de Porto Alegre

Porto Alegre, Brazil

Uniao Brasileira de Educacao e Assistencia - Hospital São Lucas da PUCRS

Porto Alegre, Brazil

Instituto D'Or de Pesquisa e Ensino

Recife, Brazil

Instituto D'Or de Pesquisa e Ensino

Rio de Janeiro, Brazil

Instituto de Educacao, Pesquisa d Gestao em Saude

Rio de Janeiro, Brazil

Instituto Nacional de Cancer - INCA

Rio de Janeiro, Brazil

Instituto do Cancer do Estado de Sao Paulo - ICESP

São Paulo, Brazil

London Regional Cancer Program London Health Sciences Centre

London, Canada

The Ottawa Hospital Cancer Center

Ottawa, Canada

Princess Margaret Cancer Center- University Health Network

Toronto, Canada

Beijing Cancer Hospital

Beijing, China

Beijing Chest Hospital, Capital Medical University

Beijing, China

Cancer Hospital of the Chinese Academy of Medical Sciences

Beijing, China

Peking Union Medical College Hospital

Beijing, China

Peking University Third Hospital

Beijing, China

Hunan Cancer Hospital

Changsha, China

West China Hospital of Sichuan University

Chengdu, China

Chongqing Cancer Hospital

Chongqing, China

Fujian Cancer Hospital

Fuzhou, China

Fujian Medical University Union Hospital

Fuzhou, China

The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, China

The First Affiliated Hospital of Sun Yat-sen University

Guangzhou, China

The First Affiliated Hospital Zhejiang University School of Medicine

Hangzhou, China

Zhejiang Cancer Hospital

Hangzhou, China

Harbin Medical University Cancer Hospital

Harbin, China

Anhui Provincial Hospital

Hefei, China

The First Affiliated Hospital of Anhui Medical University

Hefei, China

The Affiliated Hospital of Inner Mongolia Medical University

Hohhot, China

Jilin Cancer Hospital

Jilin City, China

Central Hospital Affiliated to Shandong First Medical University

Jinan, China

Shandong Cancer Hospital & Institution

Jinan, China

Yunnan Cancer Hospital

Kunming, China

The Second Affiliated Hospital of Nanchang University

Nanchang, China

Jiangsu Cancer Hospital

Nanjing, China

Jiangsu Provincial Hospital

Nanjing, China

Guangxi Medical University Cancer Hospital

Nanning, China

Shanghai Chest Hospital

Shanghai, China

Shanghai Pulmonary Hospital

Shanghai, China

ZhongShan Hospital Fudan University

Shanghai, China

The First Hospital of China Medical University

Shenyang, China

Cancer Hospital Chinese Academy of Medical Sciences, ShenZhen center

Shenzhen, China

The Fourth Hospital of Hebei Medical University

Shijiazhuang, China

Shanxi Provincial Cancer Hospital

Taiyuan, China

Taizhou Hospital of Zhejiang Province

Taizhou, China

Tianjin Medical University Cancer Institute & Hospital

Tianjin, China

The Affiliated Cancer Hospital of Xinjiang Medical University

Ürümqi, China

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology

Wuhan, China

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, China

The First Affiliated Hospital of Xi 'an Jiaotong University

Xi'an, China

Yantai Yuhuangding Hospital

Yantai, China

Henan Cancer Hospital

Zhengzhou, China

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, China

Fakultni Nemocnice Olomouc

Olomouc, Czechia

Nemocnice AGEL Ostrava-Vitkovice a.s

Ostrava, Czechia

Centre Hospitalier Universitaire d'Angers

Angers, France

HCL - Hôpital Louis Pradel

Bron, France

Centre Hospitalier Intercommunal de Creteil (CHIC)

Créteil, France

Centre Hospitalier Universitaire (CHU) Grenobles Alpes- Hôpital Albert Michallon

Hellemmes-Lille, France

Centre Hospitalier Universitaire Grenoble Alpes (CHU Grenoble Alpes) - Hopital Albert Michallon

La Tronche, France

Assistance Publique Hopitaux de Marseille (AP-HM) Hopital Nord

Marseille, France

Centre de Cancérologie du Grand Montpellier

Montpellier, France

AP-HP - Hopital Cochin

Paris, France

Assistance Publique-Hopitaux de Paris (AP-HP)- Hopital Tenon

Paris, France

Hopital Paris Saint Joseph

Paris, France

Hôpital Bichat - Claude Bernard (AP-HP)

Paris, France

Cetre Hospitalier Universitaire de Poitiers

Poitiers, France

CHU de Nantes - Saint Herblain

Saint-Herblain, France

And 54 more locations on ClinicalTrials.gov